Clinical Trials · NCT06605703
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- WW International Inc
- Enrollment
- 226
- Start date
- Sep 2024
- Locations
- 1 site, United States
- Primary endpoint
- Percent body weight change at 12 weeks